Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.

Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, Hankinson SE, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):850-5.

2.

Insulin-like growth factor-I and binding protein-3 and risk of cancer.

Giovannucci E.

Horm Res. 1999;51 Suppl 3:34-41. Review.

PMID:
10592442
3.

Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer.

Sandhu MS, Dunger DB, Giovannucci EL.

J Natl Cancer Inst. 2002 Jul 3;94(13):972-80. Review.

PMID:
12096082
4.

Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer.

Muc-Wierzgoń M, Nowakowska-Zajdel E, Dzięgielewska-Gęsiak S, Kokot T, Klakla K, Fatyga E, Grochowska-Niedworok E, Waniczek D, Wierzgoń J.

World J Gastroenterol. 2014 Aug 7;20(29):9759-74. doi: 10.3748/wjg.v20.i29.9759. Review.

5.

Diabetes and cancer: Associations, mechanisms, and implications for medical practice.

Xu CX, Zhu HH, Zhu YM.

World J Diabetes. 2014 Jun 15;5(3):372-80. doi: 10.4239/wjd.v5.i3.372. Review.

Supplemental Content

Support Center